Molecular basis of differential 3′ splice site sensitivity to anti-tumor drugs targeting U2 snRNP
Several families of natural compounds target core components of the pre-mRNA splicing machinery and display anti-tumor activity. Here the authors show that particular sequence features can be linked to drug response, and that drugs with very similar chemical structures display substantially differen...
Guardado en:
Autores principales: | Luisa Vigevani, André Gohr, Thomas Webb, Manuel Irimia, Juan Valcárcel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/51214b9023cc455398337408c0f8b445 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TSSC4 is a component of U5 snRNP that promotes tri-snRNP formation
por: Klára Klimešová, et al.
Publicado: (2021) -
Structural basis of intron selection by U2 snRNP in the presence of covalent inhibitors
por: Constantin Cretu, et al.
Publicado: (2021) -
Phylogenetic comparison and splice site conservation of eukaryotic U1 snRNP-specific U1-70K gene family
por: Tao Fan, et al.
Publicado: (2021) -
CryoEM structure of Saccharomyces cerevisiae U1 snRNP offers insight into alternative splicing
por: Xueni Li, et al.
Publicado: (2017) -
Author Correction: CryoEM structure of Saccharomyces cerevisiae U1 snRNP offers insight into alternative splicing
por: Xueni Li, et al.
Publicado: (2018)